🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
608,49 USD
Máx. histórico
608,49
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
432,53 – 614,23
Variación hoy
+1,19%
Cierre anterior
601,32
Rango de hoy
578,28 – 614,23
Volumen hoy
908.530
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,57 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 20 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 10/04/2015 | 185,98 | 188,35 | 183,91 | 184,44 | -0,22% | 2,39% | 583.500 |
| 09/04/2015 | 183,04 | 187,13 | 181,57 | 184,84 | +0,74% | 3,04% | 448.200 |
| 08/04/2015 | 179,98 | 183,58 | 179,01 | 183,49 | +2,31% | 2,54% | 641.600 |
| 07/04/2015 | 177,77 | 182,93 | 177,30 | 179,34 | +1,39% | 3,17% | 554.900 |
| 06/04/2015 | 174,36 | 177,38 | 173,25 | 176,89 | +1,24% | 2,37% | 819.500 |
| 02/04/2015 | 173,70 | 176,13 | 172,75 | 174,73 | +0,18% | 1,95% | 576.400 |
| 01/04/2015 | 172,96 | 176,50 | 169,10 | 174,41 | +1,14% | 4,28% | 826.600 |
| 31/03/2015 | 175,58 | 177,85 | 171,50 | 172,44 | -2,47% | 3,62% | 1.060.400 |
| 30/03/2015 | 174,90 | 179,29 | 174,61 | 176,81 | +2,23% | 2,68% | 652.600 |
| 27/03/2015 | 167,75 | 173,79 | 167,58 | 172,96 | +3,25% | 3,70% | 512.400 |
| 26/03/2015 | 166,48 | 169,65 | 163,57 | 167,52 | -0,20% | 3,65% | 812.300 |
| 25/03/2015 | 180,24 | 181,57 | 166,62 | 167,85 | -6,50% | 8,29% | 1.308.600 |
| 24/03/2015 | 178,13 | 180,98 | 176,95 | 179,51 | +0,44% | 2,26% | 644.700 |
| 23/03/2015 | 178,00 | 179,30 | 172,38 | 178,73 | +0,13% | 3,89% | 674.500 |
| 20/03/2015 | 176,15 | 178,85 | 172,20 | 178,49 | +1,52% | 3,78% | 1.099.900 |
| 19/03/2015 | 174,31 | 177,18 | 172,80 | 175,82 | +0,85% | 2,51% | 565.200 |
| 18/03/2015 | 176,68 | 178,21 | 172,13 | 174,34 | -1,69% | 3,44% | 629.400 |
| 17/03/2015 | 174,93 | 181,61 | 174,93 | 177,34 | +0,49% | 3,82% | 1.000.600 |
| 16/03/2015 | 164,39 | 176,65 | 163,91 | 176,48 | +8,07% | 7,75% | 1.093.100 |
| 13/03/2015 | 162,22 | 165,00 | 161,33 | 163,30 | +0,00% | 2,26% | 475.500 |
| 12/03/2015 | 165,01 | 165,62 | 162,37 | 163,30 | +0,26% | 1,97% | 380.500 |
| 11/03/2015 | 165,00 | 165,00 | 159,69 | 162,87 | -0,59% | 3,22% | 719.100 |
| 10/03/2015 | 159,24 | 164,82 | 156,85 | 163,84 | +2,12% | 5,01% | 878.800 |
| 09/03/2015 | 161,26 | 162,16 | 157,87 | 160,44 | -0,13% | 2,66% | 470.100 |
| 06/03/2015 | 160,41 | 162,21 | 158,09 | 160,65 | -0,44% | 2,57% | 627.600 |
| 05/03/2015 | 157,36 | 163,12 | 156,20 | 161,36 | +2,56% | 4,40% | 717.500 |
| 04/03/2015 | 157,02 | 159,55 | 155,38 | 157,33 | -0,26% | 2,66% | 602.200 |
| 03/03/2015 | 155,31 | 158,11 | 154,00 | 157,74 | +1,49% | 2,65% | 573.200 |
| 02/03/2015 | 154,75 | 156,23 | 153,98 | 155,42 | +0,24% | 1,45% | 497.200 |
| 27/02/2015 | 154,80 | 156,45 | 152,08 | 155,05 | -0,34% | 2,82% | 441.700 |